Novel C2,8-disubstituted adenosine derivatives disclosed herein have been found to be potent adenosine receptor agonists, in particular for the A2A receptor. The said compounds have biological activity against conditions such as hypertension, ischemic heart disease, ischemic brain disease, psychosis and wound healing. Further, the invention also discloses a process for the preparation of such compounds and pharmaceutical compositions comprising them.

 
Web www.patentalert.com

< Uncoupling of DNA insert propagation and expression of protein for phage display

< Transformation and regeneration of Allium plants

> Macrolide solvates

> Soluble complexes of amylod .beta. peptide and peptidyl prolyl isomerase chaperone and methods of making and using them

~ 00290